Hot Features
Premium
Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Período:
Tipo de Línea:
| Volume | 5,189,535 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 1,557.50 | Mínimo Máximo |
|||||
| Minimo del Dia | 1,521.50 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Gsk Plc | GSK | London | Acción Ordinaria |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 29.50 | 1.94% | 1,553.00 | 10:35:08 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1,525.00 | 1,521.50 | 1,557.50 | 1,553.00 | 1,523.50 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 6,766 | 5,189,535 | 1,548.03p | 80,335,476p | - | 1,330.20 - 1,820.00 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 12:55:55 | O | 100,321 | 1,669.26p | GBX |
| Sector Industrial de la empresa |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Información Financiera Gsk Plc GSK
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 62.72B | 4.12B | - | 30.33B | 4.93B | 1.20 | 12.99 |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Gsk Plc GSK
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 23/7/2024 | 06:07 | Alliance News |  GSK announces promising trial data for ViiV Healthcare HIV.. |
| 19/7/2024 | 04:36 | RNS Regulatory News | GSK PLC Blenrep EMA Filing Acceptance |
| 19/7/2024 | 02:12 | Alliance News | GSK drug for multiple myeloma accepted for European.. |
| 18/7/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 16/7/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 15/7/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 14/7/2024 | 05:18 | Alliance News | GSK moves to new global headquarters in return to central.. |
| 12/7/2024 | 09:30 | RNS Regulatory News | GSK PLC Director/PDMR Shareholding |
| 08/7/2024 | 07:32 | Alliance News | IN THE KNOW: UBS downgrades GSK and hacks share price target |
| 03/7/2024 | 03:22 | Alliance News | TOP NEWS: GSK inks licensing deal with CureVac for flu and.. |
| 03/7/2024 | 01:00 | RNS Regulatory News | GSK PLC GSK and CureVac collaboration restructured |
| 01/7/2024 | 09:00 | RNS Regulatory News | GSK PLC Total Voting Rights |
Histórico de Datos GSK
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,518.50 | 1,557.50 | 1,486.00 | 1,517.84 | 8,193,994 | 34.50 | 2.27% |
| 1 Month | 1,537.00 | 1,557.50 | 1,485.50 | 1,513.70 | 6,666,803 | 16.00 | 1.04% |
| 3 Months | 1,733.00 | 1,820.00 | 1,484.00 | 1,629.01 | 7,841,453 | -180.00 | -10.39% |
| 6 Months | 1,531.00 | 1,820.00 | 1,484.00 | 1,640.63 | 7,993,925 | 22.00 | 1.44% |
| 1 Year | 1,378.00 | 1,820.00 | 1,330.20 | 1,554.08 | 7,538,428 | 175.00 | 12.70% |
| 3 Years | 1,411.20 | 1,824.40 | 1,283.20 | 1,529.41 | 8,606,944 | 141.80 | 10.05% |
| 5 Years | 1,674.40 | 1,857.00 | 1,190.80 | 1,525.78 | 8,875,493 | -121.40 | -7.25% |
